IP Library Granted Patent US 7,025,869
Granted Patent B2
US 7,025,869 · App. 10/229,026 · Granted Apr 11, 2006

Nitric oxide delivery system

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,025,869
App. No.
10/229,026
Granted
Apr 11, 2006
Kind
B2
Abstract

Inhalation of low levels of nitric oxide can rapidly and safely decrease pulmonary hypertension in mammals. Precise delivery of nitric oxide at therapeutic levels of 20 to 100 ppm and inhibition of reaction of nitric oxide with oxygen to form toxic impurities such as nitrogen dioxide can provide effective inhalation therapy for pulmonary hypertension.

Claims (21)

1. A method of delivering nitric oxide to a mammal comprising:

disposing a cathode and an anode in a solution of a nitric oxide precursor that includes a precursor salt;

applying a voltage across the cathode and anode to generate nitric oxide substantially devoid of nitrogen dioxide;

contacting a transport gas with the solution of nitric oxide precursor to form a therapeutic gas; and

transporting the therapeutic gas to a mammal.

2. The method of claim 1 wherein the precursor salt includes a precursor salt concentration between 0.1% to 50%.

3. The method of claim 2 wherein the precursor salt concentration is between 1% and 20%.

4. The method of claim 1 wherein the precursor salt includes an alkali metal nitrite, alkali metal nitrate, alkaline earth metal nitrite, alkaline earth metal nitrate or ammonium nitrate.

5. The method of claim 1 wherein the nitric oxide precursor includes a salt selected from the group consisting of potassium nitrite, sodium nitrite, rubidium nitrite, strontium nitrite, barium nitrite, calcium nitrite, copper nitrite, zinc nitrite, potassium nitrate, sodium nitrate, rubidium nitrate, strontium nitrate, barium nitrate, calcium nitrate, copper nitrate and zinc nitrate.

6. The method of claim 5 wherein the nitric oxide precursor includes sodium nitrite.

7. The method of claim 1 wherein the therapeutic gas includes at least 1 ppm of nitric oxide.

8. The method of claim 1 wherein the therapeutic gas includes less than 100 ppm of nitric oxide.

9. The method of claim 1 wherein the therapeutic gas includes 20 to 60 ppm of nitric oxide.

10. The method of claim 1 wherein transporting the therapeutic gas includes releasing nitric oxide over a period of time from one hour to seven days.

11. The method of claim 1 wherein transporting the therapeutic gas includes releasing nitric oxide over a period of time from two hours to 24 hours.

12. The method of claim 1 wherein transporting the therapeutic gas includes releasing nitric oxide for at least one hour.

13. The method of claim 1 wherein the transport gas includes oxygen.

14. The method of claim 1 wherein the transport gas includes ambient air.

15. The method of claim 1 wherein the transport gas includes an air and oxygen mixture.

16. The method of claim 1 wherein the therapeutic gas is substantially devoid of nitrogen dioxide.

17. The method of claim 1 wherein contacting the transport gas with the solution of nitric oxide precursor includes flowing transport gas over the solution of nitric oxide precursor.

Assignments (6)
TERMINATION AND RELEASE OF INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Jan 3, 2024
From: RUNWAY GROWTH FINANCE CORP (F/K/A RUNWAY GROWTH CREDIT FUND INC.)
To: VERO BIOTECH INC. (F/K/A VERO BIOTECH LLC)
Reel/Frame 066186/0611 →
CHANGE OF NAME Recorded Feb 14, 2022
From: VERO BIOTECH LLC
To: VERO BIOTECH INC.
Reel/Frame 059085/0418 →
SECURITY INTEREST Recorded Dec 29, 2020
From: VERO BIOTECH LLC
To: RUNWAY GROWTH CREDIT FUND INC.
Reel/Frame 054866/0589 →
CHANGE OF NAME Recorded Aug 7, 2018
From: GENO LLC
To: VERO BIOTECH LLC
Reel/Frame 048173/0247 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 31, 2006
From: CYTERRA CORPORATION
To: GENO LLC
Reel/Frame 017397/0931 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 20, 2002
From: FINE, DAVID H.; MACDONALD, STEPHEN J.; ROUNBEHLER, DAVID; WHEELER, DAVID; ROLFE, JONATHAN L.; JARVIS, GEORGE
To: CYTERRA CORPORATION
Reel/Frame 013511/0446 →